This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics, Inc. Common stock (INTS) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsBuy This Stock Intensity Therapeutics, Inc. Common stock Earnings Summary Latest Q4 2024 Earnings DateMar. 13EstimatedConsensus EPS (Mar. 13) -$0.23 Actual EPS (Mar. 13) -$0.22 Beat By $0.01 Intensity Therapeutics, Inc. Common stock released Q4 2024 earnings on March 13, 2025, reporting an EPS of -$0.22, which beat the consensus estimate of -$0.23 by $0.01. With a trailing EPS of -$1.07, Intensity Therapeutics, Inc. Common stock's earnings are expected to grow next year, from ($1.18) to ($1.00) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Get Intensity Therapeutics, Inc. Common stock Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intensity Therapeutics, Inc. Common stock and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINTS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Intensity Therapeutics, Inc. Common stock Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.28-$0.28-$0.28Q2 20251-$0.31-$0.31-$0.31Q3 20251-$0.33-$0.33-$0.33Q4 20251-$0.35-$0.35-$0.35FY 20254($1.27)($1.27)($1.27) Intensity Therapeutics, Inc. Common stock Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/13/2025Q4 2024-$0.23-$0.22+$0.01-$0.22--8/9/2024--$0.32-$0.36 -$0.04-$0.36--5/9/2024Q1 2024--$0.34 -$0.34-$0.34--3/14/2024Q4 2023--$0.12 -$0.12-$0.12--11/13/2023Q3 2023--$0.17 -$0.17-$0.17--8/14/2023Q2 2023--$1.43 -$1.43-$1.43-- Intensity Therapeutics, Inc. Common stock Earnings - Frequently Asked Questions When did Intensity Therapeutics, Inc. Common stock announce their last quarterly earnings? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) last announced its quarterly earning data on Thursday, March 13, 2025. Learn more on INTS's earnings history. Did Intensity Therapeutics, Inc. Common stock beat their earnings estimates last quarter? In the previous quarter, Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.01. Learn more on analysts' earnings estimate vs. INTS's actual earnings. How much profit does Intensity Therapeutics, Inc. Common stock generate each year? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) has a recorded net income of -$10.54 million. INTS has generated -$1.07 earnings per share over the last four quarters. What is Intensity Therapeutics, Inc. Common stock's EPS forecast for next year? Intensity Therapeutics, Inc. Common stock's earnings are expected to grow from ($1.18) per share to ($1.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies Compugen Earnings Results Editas Medicine Earnings Results Coherus BioSciences Earnings Results Instil Bio Earnings Results Neumora Therapeutics Earnings Results Lexeo Therapeutics Earnings Results Alector Earnings Results Senti Biosciences Earnings Results C4 Therapeutics Earnings Results Zura Bio Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Markets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Market Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout This page (NASDAQ:INTS) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics, Inc. Common stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
